Growth Metrics

Gilead Sciences (GILD) EBT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 182.00
Dec 31, 2025 178.00
Sep 30, 2025 3,432.00
Jun 30, 2025 9,210.00
Mar 31, 2025 -1,137.00
Dec 31, 2024 -371.00
Sep 30, 2024 3,946.00
Jun 30, 2024 -1,287.00
Mar 31, 2024 -11,159.00
Dec 31, 2023 570.00
Sep 30, 2023 -1,473.00
Jun 30, 2023 -1,287.00
Mar 31, 2023 -1,949.00
Dec 31, 2022 -825.00
Sep 30, 2022 -2,184.00
Jun 30, 2022 -3,362.00
Mar 31, 2022 -5,791.00
Dec 31, 2021 -4,307.00
Sep 30, 2021 -1,069.00
Jun 30, 2021 -2,735.00
Mar 31, 2021 -2,251.00
Dec 31, 2020 -3,948.00
Sep 30, 2020 -5,342.00
Jun 30, 2020 -12,466.00
Mar 31, 2020 -3,289.00
Dec 31, 2019 -2,550.00
Sep 30, 2019 -8,258.00
Jun 30, 2019 -2,350.00
Mar 31, 2019 -1,449.00
Dec 31, 2018 -1,813.00
Sep 30, 2018 881.00
Jun 30, 2018 -194.00
Mar 31, 2018 283.00
Dec 31, 2017 -377.00
Sep 30, 2017 1,718.00
Jun 30, 2017 1,731.00
Mar 31, 2017 2,630.00
Dec 31, 2016 1,634.00
Sep 30, 2016 1,106.00
Jun 30, 2016 1,060.00
Mar 31, 2016 1,236.00
Dec 31, 2015 2,392.00
Sep 30, 2015 1,637.00
Jun 30, 2015 1,532.00
Mar 31, 2015 1,338.00
Dec 31, 2014 571.00
Sep 30, 2014 632.00
Jun 30, 2014 2,002.00
Mar 31, 2014 699.00